期刊文献+

GSK-3β在砷致糖代谢紊乱中的作用 被引量:1

Role of GSK-3βin arsenic-induced glucose metabolism disorders
下载PDF
导出
摘要 目的探讨GSK-3β在砷致糖代谢紊乱中的作用。方法选择SD雄性大鼠60只,随机等分为6组,C组(空白组)、L组(低砷组)、H组(高砷组)、CN组(空白GSK3抑制剂组)、LN组(低砷GSK3抑制剂组)、HN组(高砷GSK3抑制剂组),通过饮水砷染毒建立砷致糖代谢紊乱模型后,使用GSK-3β抑制剂(15 mg/kg LiCl)进行干预。ELISA检测血清胰岛素的变化情况,RT-PCR检测肝脏组织GSK-3βmRNA表达水平,WB检测肝脏GSK-3β蛋白活性。结果大鼠砷暴露15周,与对照组比较,各染砷组大鼠血糖增加,L和H组大鼠出现胰岛素抵抗;与H组比较,HN组GSK-3βmRNA表达水平降低(P<0.05);与L组比较,LN组大鼠Ser9-GSK-3β蛋白水平增高(P<0.05);与H组比较,HN组大鼠Ser9-GSK-3β蛋白水平增高(P<0.05);与L组比较,LN组GSK3β蛋白活性降低(P<0.05);与H比较,HN组GSK-3β蛋白活性降低(P<0.05)。结论砷可增加GSK-3β蛋白活性,抑制GSK-3β磷酸化,进而发生胰岛素抵抗,血糖升高,导致糖代谢紊乱。 Objective To explore the role of GSK-3βin arsenic-induced disorders of glucose metabolism.Methods Sixty SD male rats were selected and randomly divided into 6 groups,including group C(empty group),group L(low arsenic group),group H(high arsenic group),group CN(white GSK3 inhibitor group),group LN(low arsenic GSK3 inhibitor group)and group HN(high arsenic GSK3 inhibitor group).After drinking arsenic poisoning to establish a pattern of arsenic-induced glucose metabolism disorder,the GSK-3βinhibitor(15 mg/kg LiCl)was used for surgery.Serum insulin in was detected by ELISA.RT-PCR was used to detect GSK-3βmRNA expression level in liver tissue and GSK-3βprotein activity in liver was detected by Western blot assay.Results Rats were exposed to arsenic for 15 weeks.Compared to group C,the blood glucose in the arsenic-exposed groups increased and rats in the L and H groups developed insulin resistance.Compared with group H,the expression level of GSK-3βmRNA in group HN was reduced.Compared to group L,the level of Ser9-GSK-3βprotein in group LN increased.Compared to group H,the level of Ser9-GSK-3βprotein increased in group HN.Compared with group L,GSK-3βprotein activity in group LN decreased.Compared to group H,GSK3βprotein activity in group HN was decreased.Conclusion Arsenic enhances the activity of the GSK-3βprotein and inhibits GSK-3βphosphorylation and induces insulin resistance and increases blood sugar and finally causes the glucose metabolism disorders.
作者 代露露 余琴 陈中宝 周远忠 申旭波 Dai Lulu;Yu Qin;Chen Zhongbao;Zhou Yuanzhong;Shen Xubo(Laboratory of Microbiology and Immunology,School of Basic Medical Sciences,Zunyi Medical University,Zunyi Guizhou 563099,China;Department of Hygiene Toxicology,School of Public Health,Zunyi Medical University,Zunyi Guizhou 563099,China;Department of Preventive Medicine,School of Public Health,Zunyi Medical University,Zunyi Guizhou 563099,China)
出处 《遵义医科大学学报》 2021年第1期36-41,共6页 Journal of Zunyi Medical University
基金 贵州省科学技术基金资助项目(NO:黔科合SY字[2013]3032)。
关键词 砷暴露 糖代谢紊乱 大鼠 糖原合成酶激酶-3Β 磷酸化糖原合成酶激酶-3β arsenic exposure glucose metabolism disorders rats glycogen synthase kinase-3β phosphorylated glycogen synthase kinase-3β
  • 相关文献

参考文献4

二级参考文献45

  • 1Eric SA,Benjamin MT,Enrique JR,et al.Impaired insulin and insulin-like grouth factor expression and signling mechanisms in Alzheimer's disease-is this type 3 diabetes?[J].J Alzheimer's Disease,2005,7:63-80.
  • 2Ross SE.Glycogen synthase dinase-3 is an insulin-regulated C/EBP kinase[J].Mol cell Biol,1999,19:8 433-8 441.
  • 3Siegfried H.Glucose metabolism and insulin receptor signal transduction in Alzheimer's disease[J].EJ Pham,2004,490:115-125.
  • 4Grossman H.Does diabetes protect or provoke Alzheimer's disease? Insights into the pathobiology and future treatment of alzheimer's disease[J].CNS Speetr,2003,8:815-823.
  • 5Kaidanovich O,Eldar-Finkelman.The role of glycogen synthase kinase-3 in insulin resistance and Type 2 diabetes[J].Expert Opin Ther Targets,2002,6(5):555-561.
  • 6Ring DB,Johnson KW,Heriksen E J,et al.Selective glycogen synthase kinase 3 inhibitor potentiate insulin activation of glucose transport and utilization in vitro and in vivo[J].Diabetes,2003,52:588-595.
  • 7Watson GS,Craft S.The role of insulin resistance in the pathogenesis of Alzheimer's disease:implications for treatment[J].CNS Drugs,2003,17(1):27-45.
  • 8Farris W,Iansouvian S,chang Y,et al.Insulin-degrading enzyme regulates of insulin amyloid beta-protein,and the betaamyloid precursor protein intracellular domain in vivo[J].Proc Natl Acad Sci USA,2003,100:4 162-4 167.
  • 9Phiel CJ,Wilson CA,Lee VM,et al.Gsk-3 regulates production of Alzheimer's disease amyloid-βpeptides[J].Nature,2003,423:435-438.
  • 10Tomidokoro Y,Ishiguro K,Harigaya Y,et al.Abeta amyloidosis induces the initial stage of tau accumulation in APP(Sw)mice[J].Neurosci Lett,2001,23:299(3):169-172.

共引文献2133

同被引文献10

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部